Home -> Law Blog Directory -> Ethics Blogs -> Neuroethics and Law
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Ethics
: Neuroethics and LawEnhancing Ability to Deceive
By Adam Kolber
Free full text here, abstract below:
"The Truth about Lying: Inhibition of the Anterior Prefrontal Cortex Improves Deceptive Behavior"
Abstract: Recent neuroimaging studies have indicated a predominant role of the anterior prefrontal cortex (aPFC) in deception and moral cognition, yet the functional contribution of the aPFC to deceptive behavior remains unknown. We hypothesized that modulating the excitability of the aPFC by transcranial direct current stimulation (tDCS) could reveal its functional contribution in generating deceitful responses. Forty-four healthy volunteers participated in a thief role-play in which they were supposed to steal money and then to attend an interrogation with the Guilty Knowledge Test. During the interrogation, participants received cathodal, anodal, or sham tDCS. Remarkably, inhibition of the aPFC by cathodal tDCS did not lead to an impairment of deceptive behavior but rather to a significant improvement. This effect manifested in faster reaction times in telling lies, but not in telling the truth, a decrease in sympathetic skin-conductance response and feelings of guilt while deceiving the interrogator and a significantly higher lying quotient reflecting skillful lying. Increasing the excitability of the aPFC by anodal tDCS did not affect deceptive behavior, confirming the specificity of the stimulation polarity. These findings give causal support to recent correlative data obtained by functional magnetic resonance imaging studies indicating a pivotal role of the aPFC in deception.
(via Mindhacks)
Full post as published by Neuroethics and Law on January 29, 2010 (boomark / email).

Antitrust Federalism: Enhancing the Federal-State Relationship
Schapiro Testifies Before Financial Services on Enhancing Investor Protection
An Argument Against Cognitive-Enhancing Drugs








